for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Bergenbio: First Covid19 Patient Dosed With Bemcentinib In Accord Trial

June 2 (Reuters) - Bergenbio ASA:

* BERGENBIO CONFIRMS FIRST COVID19 PATIENT DOSED WITH BEMCENTINIB IN ACCORD TRIAL

* STUDY IS FULLY FUNDED BY DHSC AND UKRI AND IS BEING MANAGED BY CLINICAL RESEARCH COMPANY IQVIA. DRUG MATERIAL AND OTHER TRIAL RESOURCES WILL BE PROVIDED BY BERGENBIO

* ANTICIPATES THAT TOP LINE DATA WILL READOUT LATER IN SUMMER Source text for Eikon: Further company coverage: (Gdansk Newsroom)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up